Skip to main content
. 2016 Dec 15;2016(12):CD001904. doi: 10.1002/14651858.CD001904.pub3
Methods Randomised, parallel group, open‐label paediatric study conducted in 2 centres in the UK
4 treatment arms: CBZ, sodium valproate, phenytoin, PB
Participants Children with newly diagnosed epilepsy (2 or more untreated partial or generalised tonic‐clonic seizures in the 12 months preceding the study)
Number randomised: PB = 10, CBZ = 54 (see notes)
35 children (55%) with partial epilepsy
34 (53%) male children
Mean age (range): 9 (3 to 16) years
Range of follow‐up: 3 to 88 (months)
Interventions Monotherapy with PB or CBZ
Median daily dose achieved: PB = not stated; CBZ = 400 mg/day
Outcomes
  • Time to first seizure recurrence after start of therapy

  • Time to 12‐month remission from all seizures

  • Adverse effects and withdrawals due to adverse events

Notes 6 of the first 10 children assigned to PB had unacceptable adverse effects, so no further children were assigned to PB. The 10 children randomised to PB were retained in analysis. We received IPD for all outcomes of this review.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk A randomisation list was generated using permuted blocks of size 8 or 16 with stratification for centre, seizure type, and presence of neurological signs.
Allocation concealment (selection bias) Low risk Allocation was concealed via 4 batches of concealed opaque envelopes.
Blinding of participants and personnel (performance bias) All outcomes High risk Unblinded ‐ the authors stated that masking of treatment would not have been "practicable or ethical" and would have "undermine[d] compliance". Lack of masking could have led to early withdrawal of the PB arm from the trial.
Blinding of outcome assessment (detection bias) All outcomes High risk Unblinded ‐ the authors stated masking of treatment would not have been "practicable or ethical" and would have "undermine[d] compliance". Lack of masking could have led to early withdrawal of the PB arm from the trial, which was likely to have influenced the overall results.
Incomplete outcome data (attrition bias) All outcomes Low risk Attrition rates were reported; we analysed all randomised participants from the IPD provided²
Selective reporting (reporting bias) Low risk All outcomes were reported or calculated with the IPD provided²
Other bias Low risk We detected no other bias